Effect of combination angiotensin-converting enzyme and angiotensin receptor blocker therapy on heart failure mortality and morbidity

被引：2

作者：

Kapoor, John R.

机构：

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2008年 / 101卷 / 05期

关键词：

D O I：

10.1016/j.amjcard.2007.10.013

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：744 / 745

页数：2

共 4 条

[1]

Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors:: Where do we stand now? [J].

Boehm, Michael .

AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (3A) :38J-44J

[2]

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure [J].

Cohn, JN ;

Tognoni, G .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1667-1675

[3]

Meta-analysis: Angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction [J].

Lee, VC ;

Rhew, DC ;

Dylan, M ;

Badamgarav, E ;

Braunstein, GD ;

Weingarten, SR .

ANNALS OF INTERNAL MEDICINE, 2004, 141 (09) :693-704

[4]

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:: the CHARM-Added trial [J].

McMurray, JJV ;

Östergren, J ;

Swedberg, K ;

Granger, CB ;

Held, P ;

Michelson, EL ;

Olofsson, B ;

Yusuf, S ;

Pfeffer, MA .

LANCET, 2003, 362 (9386) :767-771

← 1 →